Microtubules, microtubule-interfering agents and apoptosis - PubMed (original) (raw)
Review
Microtubules, microtubule-interfering agents and apoptosis
F Mollinedo et al. Apoptosis. 2003 Oct.
Abstract
Microtubules are dynamic polymers that play crucial roles in a large number of cellular functions. Their pivotal role in mitosis makes them a target for the development of anticancer drugs. Microtubule-damaging agents suppress microtubule dynamics, leading to disruption of the mitotic spindle in dividing cells, cell cycle arrest at M phase, and late apoptosis. A better understanding of the processes coupling microtubule damage to the onset of apoptosis will reveal sites of potential intervention in cancer chemotherapy. Inhibition of microtubule dynamics induces persistent modification of biological processes (M arrest) and signaling pathways (mitotic spindle assembly checkpoint activation, Bcl-2 phosphorylation, c-Jun NH(2)-terminal kinase activation), which ultimately lead to apoptosis through the accumulation of signals that finally reach the threshold for the onset of apoptosis or through diminishing the threshold for engagement of cell death. Microtubules serve also as scaffolds for signaling molecules that regulate apoptosis, such as Bim and survivin, and their release from microtubules affect the activities of these apoptosis regulators. Thus, sustained modification of signaling routes and changes in the scaffolding properties of microtubules seem to constitute two major processes in the apoptotic response induced by microtubule-interfering agents.
Similar articles
- CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line.
Huang YT, Huang DM, Guh JH, Chen IL, Tzeng CC, Teng CM. Huang YT, et al. J Biol Chem. 2005 Jan 28;280(4):2771-9. doi: 10.1074/jbc.M408850200. Epub 2004 Nov 9. J Biol Chem. 2005. PMID: 15536083 - BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death.
Huang S, Tang R, Poon RY. Huang S, et al. Oncotarget. 2016 Jun 21;7(25):38718-38730. doi: 10.18632/oncotarget.9586. Oncotarget. 2016. PMID: 27231850 Free PMC article. - Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH, Jiang JD, Holland JF, Perez-Soler R. Ling YH, et al. Mol Pharmacol. 2002 Sep;62(3):529-38. doi: 10.1124/mol.62.3.529. Mol Pharmacol. 2002. PMID: 12181429 - Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents.
Whitaker RH, Placzek WJ. Whitaker RH, et al. Cells. 2019 Apr 12;8(4):346. doi: 10.3390/cells8040346. Cells. 2019. PMID: 31013740 Free PMC article. Review. - Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.
Bergstralh DT, Ting JP. Bergstralh DT, et al. Cancer Treat Rev. 2006 May;32(3):166-79. doi: 10.1016/j.ctrv.2006.01.004. Epub 2006 Mar 9. Cancer Treat Rev. 2006. PMID: 16527420 Review.
Cited by
- Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.
Last V, Williams A, Werling D. Last V, et al. BMC Neurosci. 2012 Aug 28;13:106. doi: 10.1186/1471-2202-13-106. BMC Neurosci. 2012. PMID: 22928663 Free PMC article. - Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.
Bouchet BP, Bertholon J, Falette N, Audoynaud C, Lamblot C, Puisieux A, Galmarini CM. Bouchet BP, et al. Br J Cancer. 2007 Nov 5;97(9):1218-24. doi: 10.1038/sj.bjc.6603936. Epub 2007 Oct 30. Br J Cancer. 2007. PMID: 17968427 Free PMC article. - Targeting microtubules by natural agents for cancer therapy.
Mukhtar E, Adhami VM, Mukhtar H. Mukhtar E, et al. Mol Cancer Ther. 2014 Feb;13(2):275-84. doi: 10.1158/1535-7163.MCT-13-0791. Epub 2014 Jan 16. Mol Cancer Ther. 2014. PMID: 24435445 Free PMC article. Review. - Discovery of MINC1, a GTPase-activating protein small molecule inhibitor, targeting MgcRacGAP.
van Adrichem AJ, Fagerholm A, Turunen L, Lehto A, Saarela J, Koskinen A, Repasky GA, Wennerberg K. van Adrichem AJ, et al. Comb Chem High Throughput Screen. 2015;18(1):3-17. doi: 10.2174/1386207318666141205112730. Comb Chem High Throughput Screen. 2015. PMID: 25479424 Free PMC article. - Halichondrin B amide acts as tubulin binding agent to exhibit anti-tumor efficacy in hematologic cancers.
Li YC, Zhang R, Yang Y, Li J, Zhu K, Yao K, Liu ZG. Li YC, et al. Int J Clin Exp Med. 2015 Oct 15;8(10):19662-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770630 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous